CRMD Q4 2020 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55,713+124.8% YoY

Gross Profit

-$1,520-2.7% margin

Operating Income

-$6M-10921.4% margin

Net Income

-$6M-10925.5% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-40.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$516,176

Balance Sheet

Total Assets

$49M

Total Liabilities

$5M

Stockholders' Equity

$44M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55,713	$24,779	+124.8%
Gross Profit	-$1,520	-$21,346	+92.9%
Operating Income	-$6M	-$5M	-13.2%
Net Income	-$6M	-$5M	-14.7%